Mode of action associated with development of hemangiosarcoma in mice given pregabalin and assessment of human relevance
| Autor: | Timothy Anderson, John C. Giddings, Joseph T. Brady, David Pegg, Zbigniew W. Wojcinski, James Herman, David Wesche, Kay A. Criswell, Jon C. Cook |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Pathology
medicine.medical_specialty Angiogenesis Hemangiosarcoma Metabolic alkalosis Pregabalin Pharmacology Toxicology Mice medicine Animals Humans Mode of action gamma-Aminobutyric Acid Cell Proliferation Dose-Response Relationship Drug business.industry Hypoxia (medical) Macrophage Activation medicine.disease Erythropoiesis Biomarker (medicine) medicine.symptom business medicine.drug |
| Zdroj: | Toxicological sciences : an official journal of the Society of Toxicology. 128(1) |
| ISSN: | 1096-0929 |
| Popis: | Pregabalin increased the incidence of hemangiosarcomas in carcinogenicity studies of 2-year mice but was not tumorigenic in rats. Serum bicarbonate increased within 24 h of pregabalin administration in mice and rats. Rats compensated appropriately, but mice developed metabolic alkalosis and increased blood pH. Local tissue hypoxia and increased endothelial cell proliferation were also confirmed in mice alone. The combination of hypoxia and sustained increases in endothelial cell proliferation, angiogenic growth factors, dysregulated erythropoiesis, and macrophage activation is proposed as the key event in the mode of action (MOA) for hemangiosarcoma formation. Hemangiosarcomas occur spontaneously in untreated control mice but occur only rarely in humans. The International Programme on Chemical Safety and International Life Sciences Institute developed a Human Relevance Framework (HRF) analysis whereby presence or absence of key events can be used to assess human relevance. The HRF combines the MOA with an assessment of biologic plausibility in humans to assess human relevance. This manuscript compares the proposed MOA with Hill criteria, a component of the HRF, for strength, consistency, specificity, temporality, and dose response, with an assessment of key biomarkers in humans, species differences in response to disease conditions, and spontaneous incidence of hemangiosarcoma to evaluate human relevance. Lack of key biomarker events in the MOA in rats, monkeys, and humans supports a species-specific process and demonstrates that the tumor findings in mice are not relevant to humans at the clinical dose of pregabalin. Based on this collective dataset, clinical use of pregabalin would not pose an increased risk for hemangiosarcoma to humans. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|